Resolution of Severe Pyoderma Gangrenosum in a Patient with Streaking Leukocyte Factor Disease after Treatment with Tacrolimus (FK 506)
- 1 October 1993
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 119 (7_Part_1) , 595-598
- https://doi.org/10.7326/0003-4819-119-7_part_1-199310010-00008
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.1991
- Adverse effects associated with the use of FK 506.1991
- Pyoderma gangrenosum in infancy: The youngest reported patientJournal of the American Academy of Dermatology, 1991
- A highly sensitive method to assay FK-506 levels in plasma.1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987
- Leukokinesis-enhancing factor in human serum: Partial characterization and relationship to disorders of leukocyte migrationClinical Immunology and Immunopathology, 1979
- "Streaking Leukocyte Factor," Arthritis, and Pyoderma GangrenosumPediatrics, 1975
- Effects of Tetracycline on LeukotaxisThe Journal of Infectious Diseases, 1974
- THE CHEMOSUPPRESSION OF CHEMOTAXISThe Journal of Experimental Medicine, 1966